RAPT: RAPT Therapeutics, Inc. Stock

by  •  • Comments Off on RAPT: RAPT Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 146.53
Enterprise Value ($M) -23.21
Book Value ($M) 189.90
Book Value / Share 1.44
Price / Book 0.77
NCAV ($M) 184.81
NCAV / Share 1.40
Price / NCAV 0.79

Profitability (mra)
Return on Invested Capital (ROIC) -0.67
Return on Assets (ROA) -0.83
Return on Equity (ROE) -0.99

Liquidity (mrq)
Quick Ratio 4.87
Current Ratio 4.87

Balance Sheet (mrq) ($M)
Current Assets 235.24
Assets 240.32
Liabilities 50.42
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -136.10
Net Income -129.87

Cash Flow Statement (mra) ($M)
Cash From Operations -83.30
Cash from Investing 52.70
Cash from Financing 152.85

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Redmile Group, LLC 9.90 268.89
02-14 13G/A Perceptive Advisors Llc 4.50 174.77
02-14 13G Orbimed Advisors Llc 9.90
02-07 13G/A Vanguard Group Inc 2.22 -7.09
02-07 13G/A Fmr Llc 0.40 -90.82
01-06 13G Medicxi IV LP 16.90
01-06 13G Biotechnology Value Fund L P 8.70
01-03 13G TCG Crossover GP II, LLC 9.99
12-30 13G Foresite Capital Fund VI LP 9.30
12-23 13D/A Column Group Ii, Lp 4.90 -63.76
12-23 13G Deep Track Capital, LP 9.87
11-14 13G/A Price T Rowe Associates Inc /md/ 0.50 -94.85

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-06 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-04 126,651 437,376 28.96
2025-04-03 129,914 927,585 14.01
2025-04-02 65,922 639,500 10.31
2025-04-01 189,067 690,129 27.40

(click for more detail)

Similar Companies
PAHC – Phibro Animal Health Corporation PTGX – Protagonist Therapeutics, Inc.
RANI – Rani Therapeutics Holdings, Inc. RCKT – Rocket Pharmaceuticals, Inc.
RLAY – Relay Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io